2024 NOSCM | Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cancer (NO)
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Cesar A. Santa-Maria, MD, MSCI
Disclosure
Cesar A. Santa-Maria, MD, MSCI discloses no such relationships exist
Accreditation
NA
Related Courses
-1773064384760.webp&w=3840&q=75)
2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer
0.00 AMA PRA Category 1 Credits™
1 Chapter
Breast
Free
-1773063945796.webp&w=3840&q=75)
2026 Winter Cancer Symposium | New therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs
0.00 AMA PRA Category 1 Credits™
1 Chapter
Breast
Free